Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-004006
Filing Date
2025-01-16
Accepted
2025-01-16 11:54:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm253514d2_424b3.htm 424B3 21095
2 GRAPHIC tm253514d2_424b3img001.jpg GRAPHIC 6439
  Complete submission text file 0001104659-25-004006.txt   31155
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282458 | Film No.: 25534883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)